ReviewClinics (Sao Paulo, Brazil)2018

Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy.

Ildefonso Alves da Silva Junior et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.